SandboxAQ integrates drug discovery AI models into Claude for easier access

May 18, 2026

AI Summary

SandboxAQ has partnered with Anthropic to embed its advanced drug discovery AI models into the Claude platform, allowing users to access powerful tools without needing specialized computing skills. This integration aims to simplify the drug discovery process, which is often costly and time-consuming, by providing a more user-friendly interface for researchers.

Drug discovery is a costly and lengthy process, often taking a decade and billions of dollars to find viable molecules.
SandboxAQ, an Alphabet spinout founded about five years ago, has raised over $950 million and is chaired by former Google CEO Eric Schmidt.
The company focuses on creating large quantitative models (LQMs) that are physics-grounded, enabling quantum chemistry calculations and simulations of molecular dynamics.
The integration with Claude allows users to interact with these models through a conversational interface, eliminating the need for specialized computing infrastructure.
SandboxAQ's primary customers include computational and research scientists at large pharmaceutical and industrial companies, who seek new materials for marketable products.
The company aims to address the complexities faced by researchers who have struggled with existing software solutions.

drug discoveryaccessibilitymachine learningsandboxaqclaude

SandboxAQ integrates drug discovery AI models into Claude for easier access

Related Stories

Google announces new AI-powered audio glasses in partnership with Warby Parker and Gentle Monster

Google introduces new AI models and agents to enhance user experience and compete in the market

Google introduces customizable AI agents for continuous information updates

Google I/O 2026 Introduces New AI Models and Enhanced Agent Capabilities